Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia

  1. Usall, J.
  2. López-Carrilero, R.
  3. Iniesta, R.
  4. Roca, M.
  5. Caballero, M.
  6. Rodriguez-Jimenez, R.
  7. Oliveira, C.
  8. Bernardo, M.
  9. Corripio, I.
  10. Sindreu, S.D.
  11. Piqueras, J.C.G.
  12. Felipe, A.E.
  13. De Corres, B.F.
  14. Ibáñez, A.
  15. Huerta, R.
Journal:
Journal of Clinical Psychiatry

ISSN: 0160-6689

Year of publication: 2014

Volume: 75

Issue: 6

Pages: 608-615

Type: Article

DOI: 10.4088/JCP.13M08551 GOOGLE SCHOLAR

Sustainable development goals